Neurolief, Presents

Neurolief Presents Groundbreaking Study Results of its Proliv™Rx Brain Neuromodulation Therapy for Treating Major Depression at the 7th Annual Neuropsychiatric Drug Summit

Veröffentlicht: 07.08.2025 um 18:07 Uhr, prnewswire.co.uk

Neurolief Israel Florida

View original content:https://www.prnewswire.co.uk/news-releases/neurolief-presents-groundbreaking-study-results-of-its-prolivrx-brain-neuromodulation-therapy-for-treating-major-depression-at-the-7th-annual-neuropsychiatric-drug-summit-302270190.html

en | boerse | 67948821 |